- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Dorsal onlay Oral mucosa graft urethroplasty safe treatment of female urethral stricture: Study
Dorsal onlay oral mucosa graft urethroplasty for female urethral stricture appears feasible across multiple surgeons and is associated with a low perioperative morbidity
UP: Claire Richard and colleagues demonstrated in a recent study that dorsal onlay buccal mucosal graft urethroplasty (DBMGU) for female urethral stricture is possible across various surgeons and is linked with low perioperative morbidity, good functional results, and a low recurrence rate.
The purpose of this study was to describe and evaluate the results of dorsal onlay oral mucosa transplant urethroplasty for female urethral stricture.
The findings of this study were published in the International Urogynecology Journal on 16th September 2021.
For this purpose, the researchers examined the records of all female patients who received dorsal onlay oral (buccal or lingual) mucosa urethroplasty for urethral stricture at two academic institutions between 2011 and 2020. Clinical success was defined as any subjective improvement in LUTS self-assessed by patients 1-3 months following catheter removal. Four surgeons used a uniform approach to conduct the urethroplasties: suprameatal incision, dissection and longitudinal opening of the dorsal side of the urethra, the harvest of the oral mucosa graft, and graft onlay sutured into the urethral hole.
There were 19 patients in all. At 1-3 months, the clinical success rate was 94.7%, and at one year, it was 90.9%. There was one recurrence (5.3%) after a median follow-up of 12 months (range 1-49), clinical success was obtained in 17 patients (89.5%), and both the maximal urine flow rate and post-void residual were considerably improved. At 1-3 months, the rate of de novo stress urine incontinence was 15.7%, and at 1 year, it was 9.1%
In conclusion, the study found that Dorsal onlay oral mucosa transplant urethroplasty produced favorable outcomes in females, but bigger sample sizes and longer follow-up are required to validate these findings.
The limitations of the study include the small number of cases with short follow-up.
Reference:
Richard, C., Peyronnet, B., Drain, A., Rosenblum, N., Hascoet, J., Sussman, R. D., Freton, L., Zhao, L. C., Nitti, V. W., & Brucker, B. M. (2021). Dorsal Onlay Oral Mucosa Graft Urethroplasty for Female Urethral Stricture. In Urology. Elsevier BV. https://doi.org/10.1016/j.urology.2021.09.001
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751